Abstract
Background
Endometrial cancer (EC) is most frequently seen in older and postmenopausal women.
Aim
The aim of this study was to evaluate the rate of recurrence and survival and clinical, pathological, surgical, and treatment factors affecting recurrence and survival in older patients with EC.
Methods
Three hundred and six (21.7%) patients aged ≥ 65 out of a total of 1413 patients diagnosed with and treated for epithelial EC at the Division of Gynecologic Oncology between January 1993 and May 2013 were evaluated retrospectively. All patients were staged according to FIGO 2009 staging system. Progression-free survival (PFS), cancer-specific survival (CSS), and overall survival (OS) were determined. Independent prognostic factors affecting recurrence and survival were evaluated by multivariate logistic regression analysis.
Results
The median age of the patients was 68 (65–92) years. Eighty-nine patients (29.1%) were diagnosed with stage III–IV disease. Tumor type was endometrioid in 226 (73.9%) patients, and 101 (33%) patients were diagnosed with FIGO grade 1 endometrioid endometrial cancer. One hundred fifty-three patients received adjuvant therapy after surgery. Five-year PFS, 5-year CSS, and 5-year OS were 73%, 85%, and 83%, respectively. Only the 2009 FIGO stage was independently associated with PFS (OR = 3.495, 95% CI 1.592–7.675; p = 0.002) and CSS (OR = 6.135, 95%CI 1.269–31.417; p = 0.024).
Conclusion
In conclusion, 2009 FIGO stage was found to be the only independent prognostic factor associated with recurrence and death in older patients with endometrial cancer.
Similar content being viewed by others
Availability of data and material
Data and material is available.
Change history
02 July 2021
A Correction to this paper has been published: https://doi.org/10.1007/s11845-021-02703-2
References
Applegate WB, Burns R (1996) Geriatric medicine. JAMA 275(23):1812–1813
Türkiye Sağlık Bakanlığı, Halk Sağlığı Genel Müdürlüğü (2016) Yılı Türkiye Kanser İstatistikleri. https://hsgm.saglik.gov.tr/tr/kanser-istatistikleri. Accessed 29 November 2020
United Nations, Department of Economic and Social Affairs, Population Division (2020). World Population Ageing 2019 (ST/ESA/SER.A/444). https://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAgeing2019-Report.pdf. Accessed 29 November 2020
Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90
Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424
Howlader N, Noone AM, Krapcho M, et al SEER Cancer Statistics Review, (1975-2017), National Cancer Institute. Bethesda, MD. https://seer.cancer.gov/csr/1975_2017/. Accessed 29 November 2020
Fleming ND, Lentz SE, Cass I et al (2011) Is older age a poor prognostic factor in stage I and II endometrioid endometrial adenocarcinoma? Gynecol Oncol 120(2):189–192
Vance S, Yechieli R, Cogan C et al (2012) The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma. Gynecol Oncol 126(1):16–19
Grune T, Jung T, Merker K et al (2004) Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and ‘aggresomes’ during oxidative stress, aging, and disease. Int J Biochem Cell Biol 36(12):2519–2530
Benito V, Lubrano A, Andujar M et al (2019) Management of endometrial cancer in patients aged 80 years and older: identifying patients who may benefit from a curative treatment. Eur J Obstet Gynecol Reprod Biol 242:36–42
Wright JD, Lewin SN, Medel NIB et al (2011) Endometrial cancer in the oldest old: tumor characteristics, patterns of care, and outcome. Gynecol Oncol 122(1):69–74
Hahn HS, Lee IH, Kim TJ et al (2013) Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer. Aust N Z J Obstet Gynaecol 53(3):293–297
Morrow CP, Bundy BN, Kurman RJ et al (1991) Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 40(1):55–65
Alektiar KM, Venkatraman E, Abu-Rustum N et al (2003) Is endometrial carcinoma intrinsically more aggressive in elderly patients? Cancer 98(11):2368–2377
Zaino RJ, Kurman RJ, Diana KL et al (1996) Pathologic models to predict outcome for women with endometrial adenocarcinoma: the importance of the distinction between surgical stage and clinical stage–A gynecologic oncology group study. Cancer 77(6):1115–1121
Mahdi H, Lockhart D, Maurer KA (2015) Impact of age on 30-day mortality and morbidity in patients undergoing surgery for endometrial cancer. Gynecol Oncol 137(1):106–111
Lachance JA, Everett EN, Greer B et al (2006) The effect of age on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. Gynecol Oncol 101(3):470–475
Wright JD, Lewin SN, Medel NIB et al (2011) Morbidity and mortality of surgery for endometrial cancer in the oldest old. Am J Obstet Gynecol 205(1):66. e1-e8
Reiser E, Potsch N, Seebacher V et al (2021) Impact of frailty on the management of patients with gynecological cancer aged 80 years and older. Arch Gynecol Obstet 303(2):557–563
Bourgin C, Saidani M, Poupon C et al (2016) Endometrial cancer in elderly women: which disease, which surgical management? A systematic review of the literature. Eur J Surg Oncol 42(2):166–175
Author information
Authors and Affiliations
Contributions
O.Y.C.: conceptualization, data curation, methodology, validation, writing the original draft, and review and editing. M.U.: review and editing. F.K., P.U., O.A. and C.C.: data curation, validation. G.K.C.: visualization, data curation, statistical analysis. O.T., and T.T.: supervision, methodology, validation, review, and editing.
Corresponding author
Ethics declarations
Ethics approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study protocol has been approved by the research institute’s committee on human research.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Consent for publication
All authors read and approved the final manuscript.
Conflict of interest
The authors declare no competing interests.
Additional information
The original online version of this article was revised: The original article contains an error. The value *p<0.005, given as the footnote of Table 5-6, be corrected as *p<0.05.
Rights and permissions
About this article
Cite this article
Yucel Celik, O., Unsal, M., Kilic, F. et al. Defining prognostic factors in older patients with endometrial cancer. Ir J Med Sci 191, 1123–1131 (2022). https://doi.org/10.1007/s11845-021-02663-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-021-02663-7